{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:23:46Z","timestamp":1767705826019},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1097\/jcp.0b013e31817d86cc","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T19:52:39Z","timestamp":1236282759000},"page":"452-454","source":"Crossref","is-referenced-by-count":17,"title":["Aripiprazole in a Case Presenting With Tourette Syndrome and Obsessive-Compulsive Disorder"],"prefix":"10.1097","volume":"28","author":[{"given":"Christine","family":"Winter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Kupsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Str\u00f6hle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"6","key":"R1-14-20210128","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1017\/S1461145706006833","article-title":"Aripiprazole is effective in the treatment of Tourette's disorder.","volume":"9","author":"Constant","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"R2-14-20210128","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1176\/appi.ajp.162.3.625","article-title":"Aripiprazole in a patient vulnerable to side effects.","volume":"162","author":"Dehning","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"3","key":"R3-14-20210128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1590\/S1516-44462004000300015","article-title":"Aripiprazole and Tourette syndrome.","volume":"26","author":"Hounie","year":"2004","journal-title":"Rev Bras Psiquiatr"},{"issue":"1","key":"R4-14-20210128","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/01.jcp.0000150229.69124.66","article-title":"Treatment of tics in Tourette syndrome with aripiprazole.","volume":"25","author":"Kastrup","year":"2005","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"R5-14-20210128","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4088\/PCC.v07n0605","article-title":"Aripiprazole for the treatment of Tourette's disorder.","volume":"7","author":"Padala","year":"2005","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"2","key":"R6-14-20210128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/15622970500474770","article-title":"Aripiprazole in patients with Tourette syndrome.","volume":"7","author":"Bubl","year":"2006","journal-title":"World J Biol Psychiatry"},{"issue":"7","key":"R7-14-20210128","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/hup.798","article-title":"A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole.","volume":"21","author":"Davies","year":"2006","journal-title":"Hum Psychopharmacol"},{"issue":"3","key":"R8-14-20210128","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1017\/S1461145705005365","article-title":"Case series on the use of aripiprazole for Tourette syndrome.","volume":"8","author":"Murphy","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"issue":"10","key":"R9-14-20210128","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/01.chi.0000134492.80925.96","article-title":"Case study: severe self-injurious behavior in comorbid Tourette's disorder and OCD.","volume":"43","author":"Hood","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"R10-14-20210128","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/cap.2006.16.505","article-title":"A pilot study of aripiprazole in children and adolescents with Tourette's disorder.","volume":"16","author":"Yoo","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"R11-14-20210128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4088\/JCP.v66n0107","article-title":"The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients.","volume":"66","author":"Connor","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"R12-14-20210128","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.pnpbp.2007.07.008","article-title":"Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder.","volume":"31","author":"da Rocha","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"R13-14-20210128","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4088\/JCP.v68n0624d","article-title":"Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder.","volume":"68","author":"Friedman","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"R14-14-20210128","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.jcp.0000270091.32286.0a","article-title":"Aripiprazole-induced obsessive-compulsive disorder: a report of 2 cases.","volume":"27","author":"Desarkar","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R15-14-20210128","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/da.20303","article-title":"Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder.","volume":"25","author":"Storch","year":"2007","journal-title":"Depress Anxiety"},{"issue":"3","key":"R16-14-20210128","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0193-953X(05)70181-7","article-title":"Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder.","volume":"23","author":"Saxena","year":"2000","journal-title":"Psychiatr Clin North Am"},{"key":"R17-14-20210128","first-page":"369","article-title":"Tourette Syndrome.","volume":"85","author":"Jankovic","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"R18-14-20210128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/10401230490522016","article-title":"Risperidone augmentation in the treatment of severe adolescent OCD in SSRI-refractory cases: a case-series.","volume":"16","author":"Thomsen","year":"2004","journal-title":"Ann Clin Psychiatry"},{"issue":"9","key":"R19-14-20210128","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archpsyc.1979.01780090065007","article-title":"Effects of dopamine agonists and antagonists in Tourette's disease.","volume":"36","author":"Feinberg","year":"1979","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"R20-14-20210128","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10072-005-0448-z","article-title":"Pergolide improvement in neuroleptic-resistant Tourette cases: various mechanisms causing tics.","volume":"26","author":"Cianchetti","year":"2005","journal-title":"Neurol Sci"},{"issue":"1","key":"R21-14-20210128","first-page":"55","article-title":"Quetiapine and obsessive-compulsive symptoms (OCS): case report and review of atypical antipsychotic-induced OCS.","volume":"26","author":"Khullar","year":"2001","journal-title":"J Psychiatry Neurosci"},{"issue":"1","key":"R22-14-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(91)90196-U","article-title":"Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia.","volume":"41","author":"Grace","year":"1991","journal-title":"Neuroscience"},{"key":"R23-14-20210128","first-page":"177","article-title":"Clinical symptomatology, CSF neurotransmitter metabolites, and serum haloperidol levels in Tourette syndrome.","volume":"35","author":"Singer","year":"1982","journal-title":"Adv Neurol"},{"issue":"5279","key":"R24-14-20210128","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1126\/science.273.5279.1225","article-title":"Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding.","volume":"273","author":"Wolf","year":"1996","journal-title":"Science"},{"issue":"8","key":"R25-14-20210128","first-page":"1243","article-title":"D2-like dopamine receptor density in Tourette syndrome measured by PET.","volume":"38","author":"Wong","year":"1997","journal-title":"J Nucl Med"},{"issue":"8","key":"R26-14-20210128","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1176\/appi.ajp.159.8.1329","article-title":"Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET.","volume":"159","author":"Singer","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"9","key":"R27-14-20210128","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1176\/appi.ajp.2007.06091479","article-title":"Differential effects of aripiprazole on D2, 5-HT2, and 5-HT1A receptor occupancy in patients with schizophrenia: a triple tracer PET study.","volume":"164","author":"Mamo","year":"2007","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-200808000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:13:20Z","timestamp":1618035200000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-200808000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31817d86cc","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}